These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5495986)

  • 1. Indomethacin-induced intestinal lesions in the rat.
    Brodie DA; Cook PG; Bauer BJ; Dagle GE
    Toxicol Appl Pharmacol; 1970 Nov; 17(3):615-24. PubMed ID: 5495986
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of cholestyramine and synthetic hydrotalcite on acute gastric or intestinal lesion formation in rats and dogs.
    Ishihara Y; Okabe S
    Dig Dis Sci; 1981 Jun; 26(6):553-60. PubMed ID: 7238276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal ulcers and intestinal flora in rats given indomethacin.
    Kent TH; Cardelli RM; Stamler FW
    Am J Pathol; 1969 Feb; 54(2):237-49. PubMed ID: 5765565
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of gastric cytoprotective drugs (atropine, cimetidine, vitamin-A) on the indomethacin induced intestinal ulcers in rats.
    Beró T; Németh A; Mózsik G; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):343-7. PubMed ID: 6532122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Inhibitory effect of cholestyramine on the intestinal ulcer formation in rats given an antiphlogistic agent.
    Takemoto K; Tanaka K
    Gastroenterology; 1974 Oct; 67(4):765-6. PubMed ID: 4414269
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
    Miyazawa T; Matsumoto M; Kato S; Takeuchi K
    Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the liver in the prevention of indomethacin-induced intestinal ulcers by spironolactone.
    Selye H
    Acta Hepatosplenol; 1970; 17(6):393-7. PubMed ID: 5490556
    [No Abstract]   [Full Text] [Related]  

  • 8. Some studies on the rodenticidal action of indomethacin.
    Omogbai EK; Ozolua RI; Idaewor PE; Isah AO
    Drug Chem Toxicol; 1999 Nov; 22(4):629-42. PubMed ID: 10536753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intestinal ulcer due to indomethacin].
    Cristini C; Mariani L
    Arch Sci Biol (Bologna); 1972; 56(2):115-21. PubMed ID: 4669297
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship of the enterohepatic cycle to ulcerogenesis in the rat small bowel with flufenamic acid.
    Wax J; Clinger WA; Varner P; Bass P; Winder CV
    Gastroenterology; 1970 Jun; 58(6):772-80. PubMed ID: 5423889
    [No Abstract]   [Full Text] [Related]  

  • 11. Factors influencing the indomethacin-induced intestinal lesions in the rat.
    Mariani L
    Eur J Toxicol Environ Hyg; 1975; 8(6):335-9. PubMed ID: 1204671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin: intestinal damage in rats.
    Brodie DA; Tate CL; Hooke KF
    Science; 1970 Oct; 170(3954):183-5. PubMed ID: 5456612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
    Nishio H; Hayashi Y; Terashima S; Takeuchi K
    Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-salicylate in contrast with acetylsalicylic acid prevents gastric antral and intestinal ulcers produced by indomethacin in the refed rat.
    Ezer E
    Acta Physiol Hung; 1985; 65(3):263-6. PubMed ID: 4013765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.
    Somasundaram S; Rafi S; Hayllar J; Sigthorsson G; Jacob M; Price AB; Macpherson A; Mahmod T; Scott D; Wrigglesworth JM; Bjarnason I
    Gut; 1997 Sep; 41(3):344-53. PubMed ID: 9378390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 16, 16-dimethyl prostaglandin E2 methyl ester on aspirin-and indomethacin-induced gastrointestinal lesions in dogs.
    Tabata K; Okabe S
    Dig Dis Sci; 1980 Jun; 25(6):439-48. PubMed ID: 7379677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
    Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
    J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of corticosteroids on indomethacin-induced intestinal ulceration in the rat.
    Derelanko MJ; Long JF
    Dig Dis Sci; 1980 Nov; 25(11):823-9. PubMed ID: 7438955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat.
    Whittle BJ
    Gastroenterology; 1981 Jan; 80(1):94-8. PubMed ID: 6778761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.